Oncology & Hematology Coding Alert
Reader Question:
Follow-up Care is Key to Xofigo Coding
Published on Mon Nov 14, 2016
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
Other Articles in this issue of
Oncology & Hematology Coding Alert
- Coding Strategy:
Doctor Prescribing Venetoclax for CLL Patients? Here's What to Submit
Keep documentation for patient selection and any prior treatment. Have you been coding accurately for [...] - News You Can Use:
ASTRO Makes Clear Recommendations For Justified RVUs In 2017
Arbitrary crosswalks may mislead; RUC recommendations should be considered. Are you curious how your relative [...] - CMS Announced End To Flexibilities Beyond Oct. 1, 2016
Practices have no option but to adopt specificity and accuracy. ICD-10-CM codes apply to your [...] - ICD-10-CM Update:
Look Beyond Cancer Diagnosis Codes To Capture All Complaints
Fatigue and malaise may not be clearly differentiated but they have separate codes. Watch out [...] - You Be the Coder:
Confirm Chemotherapy in High-Risk Medication
Question: Our physician is treating a pregnant woman with chemotherapy. This is clearly use of a [...] - Reader Question:
Split Services Mandate Same Patient and Same Date
Question: Is a common date of service mandatory for split visits? Do visits in outpatient and [...] - Reader Question:
Never Ignore Carrier State Confirmation
Question: Our physician has documented a family history of thalassemia carrier state. Do we need to [...] - Reader Question:
Follow-up Care is Key to Xofigo Coding
Question: In a patient with advanced resistant prostate cancer, our oncologist administered radium Ra 223 (Xofigo). [...] - Reader Question:
Counselling Time Determines E/M Coding
Question: How can we effectively report for counselling services of our provider? Is counselling a part [...]
View All
